Claudia is Head of the Corporate and Financial Services Practice Group. As a corporate finance lawyer, she has over 20 years of experience in corporate and securities laws, advising on landmark, cross- border, merger and acquisition transactions in addition to initial public offerings and compliance issues on the Singapore Stock Exchange. Some of her complex deal structures have focused on various industries including healthcare and pharmaceuticals, fintech, natural resources, lifestyle and real estate and construction.
Before joining the Firm, Claudia practiced with a local law firm and an international law firm in Singapore. Prior to that, she lived and worked abroad for 12 years in both London and Hong Kong, where she also practiced with two Hong Kong law firms, advising on initial public offerings and compliance issues on the Hong Kong Stock Exchange.
Claudia is recommended in the 2016 edition of The Legal 500 as well as in the 2014 edition of Asialaw’s Leading Lawyer Publication. She has been described by Asia Pacific Legal 500 as having a ‘flexible, walk-the-extra-mile approach’ and ‘always goes the extra mile’. One of her clients has described her team as “very intelligent and incisive lawyers, absolutely focused on helping [us] achieve our objectives” in Asialaw Profiles 2016. Her Practice Group was awarded various accolades by leading legal publications, ranked in 2013, 2014 and 1H 2015 in the Bloomberg Global Legal Adviser League Tables and most recently in the Asian Legal Business - M&A Ranking 2016 as one of the notable firms in Singapore.
Claudia sits as a member of the investment committee of Ren Ci Hospital & Medicare Centre, a Singapore charity. She is also an independent director of iX Biopharma Ltd, an innovative late-stage specialty pharmaceutical company with expertise in drug delivery and formulation. Claudia was called to the Singapore Bar and is dually qualified as a barrister and a solicitor of England and Wales and is admitted to the Rolls of Solicitors of Hong Kong.